Compare SNY & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNY | BX |
|---|---|---|
| Founded | 1994 | 1985 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 121.9B |
| IPO Year | N/A | 2007 |
| Metric | SNY | BX |
|---|---|---|
| Price | $47.08 | $149.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 15 |
| Target Price | $61.50 | ★ $178.47 |
| AVG Volume (30 Days) | 2.8M | ★ 3.2M |
| Earning Date | 01-29-2026 | 01-29-2026 |
| Dividend Yield | ★ 3.39% | 2.62% |
| EPS Growth | ★ 105.93 | 19.48 |
| EPS | ★ 8.67 | 3.48 |
| Revenue | ★ $53,890,648,839.00 | $12,791,218,000.00 |
| Revenue This Year | $1.73 | $4.47 |
| Revenue Next Year | $6.49 | $24.33 |
| P/E Ratio | ★ $10.54 | $43.25 |
| Revenue Growth | N/A | ★ 14.84 |
| 52 Week Low | $44.62 | $115.66 |
| 52 Week High | $60.12 | $190.09 |
| Indicator | SNY | BX |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 42.61 |
| Support Level | $45.25 | $153.81 |
| Resistance Level | $48.17 | $165.14 |
| Average True Range (ATR) | 0.78 | 5.03 |
| MACD | -0.10 | -0.92 |
| Stochastic Oscillator | 44.74 | 14.56 |
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).